The antidepressant-and anxiolytic effects of asarone (AN) were investigated by means of behavioral pharmacology for the first time. The other central-acting properties of AN were also examined to see whether clear differences could be observed between it and diazepam (DZ).
AN (3.5,7 mg/kg) reduced the duration of immobility in the forced swimming test. AN (3.5,7 mg/kg) produced a reduction in immobility in the tail suspension test. Ptosis and dyskinesia in reserpine-treated mice were significantly inhib...